Biotech Stocks: Enterprise Value / EBITDA

by: Robert Zenilman

Rob Zenilman submits: As of July 25, 2006, positive (Enterprise Value)/(EBITDA) ratios of stocks covered in the Biotech sector ranged from 140.2 (NASDAQ:CELG) down to 6.3 (BSTE), with a median value of 15.3.

* View More Biotech Sector Charts *

Data in table version -- click on a ticker for opinion and analysis of the company:


TTM Enterprise EBITDA EV/
Ticker Company Ending Value ($000) ($000) EBITDA
AFFX Affymetrix Inc. 05/10/06 $1,314.07 $75.48
17.4
ALXN Alexion Pharmaceutic 05/05/06 $1,032.36 -$132.59
-7.8
AMGN Amgen Inc. 07/20/06 $83,391.10 $6,065.00
13.7
AMLN Amylin Pharmaceutica 05/05/06 $6,130.75 -$215.04
-28.5
BIIB Biogen Idec Inc. 05/10/06 $13,482.09 $998.58
13.5
BMRN BioMarin Pharmaceuti 05/04/06 $1,212.58 -$38.99
-31.1
BSTE Biosite Incorporated 05/10/06 $659.54 $105.21
6.3
CELG Celgene Corporation 05/10/06 $16,507.95 $117.74
140.2
DNA Genentech Inc. 07/11/06 $86,346.95 $3,105.27
27.8
ELN Elan Corp. plc 05/04/06 $6,901.46 -$116.70
-59.1
GILD Gilead Sciences Inc. 07/20/06 $24,861.27 $1,467.59
16.9
GPRO Gen-Probe Inc. 05/05/06 $2,588.12 $116.16
22.3
IMCL Imclone Systems Inc. 07/20/06 $1,960.81 $222.18
8.8
INCY Incyte Corp. 05/04/06 $383.46 -$93.65
-4.1
ISTA ISTA Pharmaceuticals 05/10/06 $142.84 -$41.49
-3.4
KOSP KOS Pharmaceuticals 05/10/06 $1,442.37 $180.33
8.0
MEDI MedImmune Inc. 07/20/06 $5,608.65 $83.70
67.0
NABI Nabi Biopharmaceutic 05/05/06 $345.38 -$75.39
-4.6
NBIX Neurocrine Bioscienc 07/17/06 $123.29 -$36.35
-3.4
ONXX Onyx Pharmaceuticals 05/10/06 $418.09 -$103.66
-4.0
PGNX Progenics Pharmaceut 05/09/06 $400.78 -$58.91
-6.8
PHRM Pharmion Corp. 05/10/06 $342.63 $34.42
10.0
TELK Telik Inc. 05/05/06 $716.75 -$77.74
-9.2
VRTX Vertex Pharmaceutica 05/10/06 $3,762.58 -$119.45
-31.5

Data: Capital IQ

Related:

  1. Most recent opinion and analysis of Biotech stocks
  2. Full transcripts of recent conference calls in the Biotech sector
  3. Add the Biotech Stock Blog to your My Yahoo! page

Aside: Did you know that Seeking Alpha now publishes a one-page recap of Jim Cramer's Mad Money stock picks?